IDEX Corp’s stock price has taken a 4.79% hit due to market volatility, amid concerns over a possible global recession triggered by US President Trump’s tariffs.
IDEX Corporation exceeded analyst expectations in its Q4 performance, driven by strong sales in its health and science technology segment, and projects steady growth for 2025.